• Brittany Bannon, PhD

    Brittany Bannon, PhD

    Dr. Bannon received her PhD in Social/Personality Psychology with a concentration in Health from University of California, Riverside. Brittany’s research is targeted at the psychosocial predictors and development of illness behaviors- that is, variability in people's responses to symptoms, including the propensity to seek out treatment and health services. By applying psychological models of health behavior change within a developmental framework, her research centers on disentangling the psychosocial and biological mechanisms that underlie these behaviors during various lifespan transitions. Email: brittany.bannon@hsc.utah.edu

  • Christopher Cambron, PhD

    Christopher Cambron, PhD

    Dr. Cambron received his PhD in Social Welfare and a graduate certificate in Demographic Methods from the University of Washington and has master’s degree in Social Work and Public Policy from the University of Utah. Chris' doctoral research examined socioeconomic, social context, and public policy influences on substance use and abuse across the life course. At the Huntsman Cancer Institute, Chris is working with the Center for Health Outcomes and Population Equity (HOPE) and exploring socioeconomic disparities in smoking cessation with the goal of reducing cancer risk among historically disadvantaged populations. Email: chris.cambron@hci.utah.edu

  • Rebecca Delaney, PhD

    Rebecca Delaney, PhD

    Dr. Delaney received her PhD in Life-Span Developmental Psychology from West Virginia University. Rebecca’s research is targeted at understanding how individual differences, such as age and gender, can influence behaviors and decisions that lead to significant health outcomes. Through this research she hopes to identify factors that inform intervention development to aid aging men and women with making advantageous health decisions and enhance physician-patient relationships when considering important healthcare decisions. Email: rebecca.delaney@hsc.utah.edu

  • Laurie Grieshober, MA, PhD

    Laurie Grieshober, MA, PhD

    Dr. Grieshober earned her PhD in Epidemiology from the University of Buffalo where she was a pre-doctoral NCI R25 trainee in Interdisciplinary Cancer Epidemiology. Prior to her PhD, Laurie completed an MA in Mathematics at the same institution. Based on her work to date, Laurie brings expertise in telomeres and aging, race/ethnic disparities, and various phenotypes including breast cancer risk and survival as well as sleep duration and quality. By identifying factors associated with disease processes and ‘healthy’ aging, Laurie hopes to reduce the impact and resultant burden of chronic disease. At the Huntsman Cancer Institute, Laurie is developing research projects on lung cancer survivorship, particularly related to anti-PD-1 therapies, and on modifiable factors for ovarian cancer survivorship. Email: Laurie.Grieshober@hci.utah.edu

  • Andreana N. Holowatyj, PhD, GCPHP

    Andreana N. Holowatyj, PhD, GCPHP

    Dr. Holowatyj recently graduated with her PhD in Cancer Biology and a Graduate Certificate in Public Health Practice from the Wayne State University School of Medicine and Barbara Ann Karmanos Cancer Institute in Detroit, Michigan. During her doctoral tenure, she was the recipient of national and international awards where her research focused on the intersection of molecular epidemiology and cancer disparities. She also developed a strong expertise in epigenetics and chromatin modifications in tumorigenesis. At the Huntsman Cancer Institute, the focus of her research in Dr. Ulrich’s group is to elucidate the molecular underpinnings (genome, transcriptome, metabolome, microbiome) of young-onset colorectal cancer using data from ColoCare, FOCUS, MetaboCCC, and other international consortia. In addition, her research work aims to explore the role of folate one-carbon metabolism, NSAID pharmacogenetics, and metabolic syndrome in colorectal cancer prognosis. Andreana was recently awarded a NIH Ruth L. Kirschstein National Research Service Award T32 Post-Doctoral Fellowship Training Grant from the National Human Genome Research Institute Training in Genomic Medicine program. She is now also pursuing her Master’s of Science degree in Clinical Investigation at the School of Medicine. Andreana is also involved with the American Association for Cancer Research (AACR), including as an invited panelist at the 2017 AACR Congressional Briefing. Email: Holowatyj@hci.utah.edu